address in Biological Technology

Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22

MEDIA ALERT WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Focusing on critical healthcare reform efforts and best practices essential to reducing preventable adverse events, and responding to President Obama's bold principles for change, influential leaders will gather at the National Patient...

SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal

MUNICH, May 15 /PRNewswire/ -- - Investigating the Real Burden of Hypertension, Addressing the Challenges of Getting to Blood Pressure Goal and SHARE(ing) the Knowledge ( http://www.SHARE-hypertension.com ) The SHARE steering committee announce the launch of Supporting Hypertensi...

The University of Arizona College of Medicine and OmegaGenesis Announce Collaboration Agreement to Address Diabetic Foot Ulcers

TUCSON, Ariz., and GILROY, Calif., April 6 /PRNewswire/ -- The Department of Surgery at The University of Arizona College of Medicine and OmegaGenesis, Inc., announced an agreement to collaborate on potential remedies to address diabetic foot ulcers. The agreement includes joint work in s...

PAREXEL Experts to Address Benefits of Rigorous Early Phase Development at Annual ASCPT Meeting

BOSTON, March 16 /PRNewswire/ -- PAREXEL experts will address the benefits of rigorous early phase clinical development at the 110th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), to be held at the Gaylord National Resort in National Harbor, Maryland fro...

PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009

BOSTON, March 12 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia/Pacific Region at PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will present "The True Value of Incorporating Asia into a Global C...

Frost & Sullivan's Biopharmaceuticals Market Briefing to Address the Use of Embryonic Stem Cells

MOUNTAIN VIEW, Calif., March 4 /PRNewswire/ -- The Healthcare practice at Frost & Sullivan is pleased to announce its 2009 Quarterly Analyst Briefing Presentation on the North American biopharmaceuticals market to be held on Thursday, March 5, 2009 at 10:00 a.m. PST. (Logo: http://www...

Environmental Tectonics Corporation's BioMedical Division's Hyperbaric Chambers Address U.S. President Obama's Initiative to Computerize Medical Records

SOUTHAMPTON, Pa., Feb. 23 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation (Amex: ETC ) ("ETC" or the "Company") today announced that their BioMedical Division's Hyperbaric Chambers are equipped to satisfy the requirements of Electronic Medical Records (EMR) compilation. In a ...

M2S Expert gives address "Applying the Principles of Six Sigma in the Imaging Core Lab" at Imaging for Clinical Trials conference

M2S Expert Dr. Steven Marra will give the featured address entitled "Applying the Principles of Six Sigma in the Imaging Core Lab" at the Center for Business Intelligence (CBI) 6th Annual Imaging for Clinical Trials conference. Dr. Marra's presentation will examine how the application o...

Victhom announces the filing of a patent application to address sudden unexplained death in epilepsy (SUDEP)

QUEBEC, Feb. 11 /PRNewswire-FirstCall/ - Victhom Human Bionics Inc., "Victhom" (TSX: VHB), announced today the filing of a patent application for the detection and treatment of a physiological disorder that most likely leads to sudden unexplainable death in epileptic patients during seizure. Vic...

GenVault Opens Japanese Subsidiary to Better Address Global Biobanking Market Growth

GenVault's energy and space efficient technologies ideally suit the needs of the Japanese Biobanking community, and create a new paradigm for eco-friendly, sustainable Biobanking initiatives. CARLSBAD, Calif., Jan. 26 /PRNewswire/ -- GenVault Corporation today announces the opening of its new...

DoD Leader to Address Presidential Biometrics Security Directive at NDIA Conference

General Victor E. Renuart, Jr., will address attendees regarding the implementation of Homeland Security Presidential Directive/HSPD – 24 at the 2009 Biometrics Conference www.ndia.org/meetings/9860 on January 27-28, 2009 at the Sheraton National Hotel in Arlington, VA. ...

PAREXEL Expert to Address Key Aspects of Conducting Clinical Trials in China at 7th Annual Partnerships in Clinical Trials Congress

BOSTON, Nov. 3 /PRNewswire-FirstCall/ -- Albert Liou, Corporate Vice President and General Manager, Asia-Pacific Region, at PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, will present "What Can China Really Deliver in Terms of Cost and...

Histogen Aesthetics is Created to Address Growing Medical Aesthetics Market

Dr. Lawrence A. Rheins Joins Histogen Aesthetics as President San Diego/Phoenix (PRWEB) October 20, 2008 -- Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn dermal fibroblasts, today announced the creation of Histoge...

Vaxfectin(R)-formulated Measles DNA Vaccine Could Address Unmet Need for Infants

SAN DIEGO, Aug. 21 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced that results from nonhuman primate studies of a Vaxfectin(R)-formulated DNA vaccine for measles, published in the August issue of Clinical and Vaccine Immunology(1), offer a promising approach to t...

PAREXEL Experts to Address Key Industry Topics at the Drug Information Association 44th Annual Meeting

BOSTON, June 16 /PRNewswire-FirstCall/ -- Experts from PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services organization, will present in more than 20 sessions at the Drug Information Association (DIA) 44th Annual Meeting. The meeting will be held Jun...

Microsoft scientist highlights urgent need for new computer models to address climate change

Two papers published in the journal Science today* by Microsoft Research ecologist Drew Purves together with research colleagues at Princeton University and universities in Madrid, Spain, highlight how an improved understanding of forest dynamics is needed to better predict environmental change. T...

IDF Urges Healthcare Providers to Address the Relationship Between Type 2 Diabetes and Sleep Apnea

Treating These Closely-Related Conditions Requires New Clinical Practices and Research to Reduce Personal and Public Health Costs SAN FRANCISCO and BRUSSELS, June 7 /PRNewswire/ -- The International Diabetes Federation (IDF) Task Force on Epidemiology and Prevention warned today that rec...

More Can Be Done Now to Address the Growing Global Demand for Grain

Increasing Yields the Best Option, Says DuPont Leader at UN Food and Agriculture Conference ROME, June 3 /PRNewswire-FirstCall/ -- More can be done now to increase the amount of grain farmers harvest from their land and help address the strong and growing global deman...

Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease

The Alzheimer's Study Group Outlines a National Plan WASHINGTON, May 14 /PRNewswire-USNewswire/ -- Today, retired U.S. Supreme Court Justice Sandra Day O'Connor and Former Speaker of the House Newt Gingrich presented testimony to a special hearing of the U.S. Senate Special Committee...

Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally

DEERFIELD, Ill., March 10 /PRNewswire/ -- Baxter International Inc. and The Baxter International Foundation, the philanthropic arm of Baxter, today announced their combined 2007 charitable giving, which focused on increasing access to healthcare, helping developing nations and countries in cri...

MUSC's Kilpatrick to Address Congress Regarding PTSD Care

Renowned Psychologist Reports Problems in VA System for Veterans with PTSD CHARLESTON, S.C., Feb. 26 /PRNewswire-USNewswire/ -- Dean Kilpatrick, Ph.D., MUSC distinguished university professor and director of the National Crime Victim's Research and Treatment Center at MUSC's Institute of Psychi...

National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego

Tuesday February 26, 2008 9:15 am ET MOUNTAINSIDE, N.J., Feb. 26 /PRNewswire-FirstCall/ -- National Stem Cell Holding, Inc. (Pink Sheets: NHGI) today announced that its President Michael Cohen will present a Keynote Address, "A New Collaboration Model for Government Agencies,...

KGI Announces BIO President Greenwood to Address Health Care Reform and the Presidential Race at Simon Ramo Lecture

CLAREMONT, Calif., Feb. 12 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that James Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), will discuss "The American Health Care System & the Presidential Race: Who Will Regulate, Who Will Innovate?" at th...

Monsanto Executives to Address Investor Conferences in February

ST. LOUIS, Feb. 5 /PRNewswire-FirstCall/ -- Monsanto Company's (NYSE: MON) Brett Begemann, executive vice president of global commercial business, and Carl Casale, executive vice president of strategy and operations, will address investors in separate presentations at two conferences later thi...

AMT's Lead Product Poised to Address Major Liver Disease

AMSTERDAM, The Netherlands, January 28 /PRNewswire-FirstCall/ -- - European Patent Office Grants Patent for Treatment of Non-Alcoholic Steatotic Hepatitis AMT (Euronext: AMT), a leader in the field of human gene therapy, today announced that the European Patent Office (EPO) has granted the...

White Paper Details Infection Control Challenges Hospitals Must Address During Construction

NEEDHAM, Mass., Jan. 22 /PRNewswire/ -- Hospitals and healthcare institutions are challenged to devise policies and procedures that allow construction projects to take place while maintaining Environment of Care (EC) standards. A free white paper that addresses these challenges is available fo...

Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA

SAN MARINO, Calif., Oct. 18 /PRNewswire/ -- Epeius Biotechnologies Corporation today announced that Dr. Frederick L. Hall, President and CEO of Epeius Biotechnologies Inc., has accepted an invitation to give the lead keynote address on "The Advent of Pathotropic Medicine for Cancer" at the Glo...

U.S. Commerce Secretary Gutierrez to Address AdvaMed 2007

Plenary Speaker Hall of Fame Coach Jim Calhoun Credits Early Diagnosis with Saving his Life WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Day two of AdvaMed 2007: The MedTech Conference will highlight how everyday patients are heroes and benefit from advancements in medical technology as we...

Statewide IT association will address IT issues and priorities

Madison, Wis. Information technology professionals in Wisconsin announced on Monday the formation of the Information Technology Association of Wisconsin, a forum for information exchange and issue advocacy by a sector that generates more than $14B in revenue and hires more than 55,000 employee...

Conference to address small town development

Menomonie, Wis. - The West Central Wisconsin Workforce Resource is inviting representatives from business, education, and government to participate in its 2006 Synergy Conference titled "Positioning for Economic Growth." The conference is scheduled to take place on Sept. 20 from 8 a.m. to 5 ...

KV Pharmaceutical Announces Stockholder Action to Amend By-Laws is Invalid

...e," "commit," "intend," "estimate," "will," "should," "could" and other expressions that indicate future events and trends. All statements that address expectations or projections about the future, including without limitation, product development, product launches, regulatory approvals, market positi...

Novavax Reports Second Quarter 2009 Financial Results

... agreements, as opportunities arise. About Novavax Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, ...

Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results

...ntended for the treatment of a serious or life-threatening condition for which there is no effective treatment and which demonstrates the potential to address unmet medical needs. For more information about the Company, go to www.catalystpharma.com . This press release contains forward-looking stat...

Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer

...degree in accounting from Bentley College. About Novavax Novavax, Inc. is a clinical-stage biotechnology company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The company produces ...

OncoGenex Reports Second Quarter 2009 Financial Results

...About OncoGenex Pharmaceuticals OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address unmet needs in the treatment of cancer. OncoGenex has a deep oncology pipeline, with each product candidate having a distinct mechanism of action and ...

Webcast Alert: Transgenomic Inc. Announces Second Quarter 2009 Earnings Release Conference Call Webcast

... Where: http://www.transgenomic.com/events.asp?id=6 How: Live over the Internet -- Simply log on to the web at the address above. Contact: Investor Relations, 402-452-5400 To access the call via telephone, call 800-894-5910 or 785-424-1052. A replay...

Optimer Pharmaceuticals Reports Second Quarter 2009 Financial Results

... a biopharmaceutical company focused on discovering, developing and commercializing innovative anti-infective products to treat serious infections and address unmet medical needs. Optimer has two late-stage anti-infective product candidates under development. Fidaxomicin, formerly known as OPT-80, is the onl...

The Foundation for National Institutes of Health Announces Unprecedented Product Donation by sanofi-aventis in the U.S.

...es private-sector funds for a broad portfolio of unique programs that complement and enhance NIH priorities and activities. The Foundation's Web site address is http://www.fnih.org . The NIH - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S...

Omeros Appoints New Vice President of Clinical Development

...gery platform," said Dr. Murray. "In addition, we have several preclinical central nervous system and inflammation programs that have the potential to address significant unmet medical needs. This is an important time for Omeros and I'm excited to play a role here." Prior to Omeros, Dr. Murray served ...

SK Life Sciences has Licensed Pristima

...ment of SK Life Science, Inc., remarked that "SKLSI is building its research and development arm and required the most modern toolset in order to address current and future projects." About SK Life Sciences - SK Life Science, Inc. ( http://pharma.sk.com/english ), US subsidiary of SK Holdings, ...